Pre-Immunization and Immunotherapy in HIV(+) Patients
Country:
US
Docket No:
436313-001136
Publication Number:
10,494,647
Patent Expiry:
08/03/2037
Claims Scope:
Patent issued December 3, 2019.
AGT approved strategy of adding SEQ ID NOs: 1, 2, and 3 (sequences containing microRNA backbone and guide sequences) to the independent claims to address rejections.
